These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 15080495)
1. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines. Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495 [TBL] [Abstract][Full Text] [Related]
2. [Sequence analyses of aberrant FHIT transcripts in gastric cancer cell lines]. Lee SH; Kim HS Korean J Gastroenterol; 2003 Dec; 42(6):476-83. PubMed ID: 14695704 [TBL] [Abstract][Full Text] [Related]
3. Characterization of aberrant FHIT transcripts in gastric adenocarcinomas. Lee SH; Kim CJ; Park HK; Koh JW; Cho MH; Baek MJ; Lee MS Exp Mol Med; 2001 Sep; 33(3):124-30. PubMed ID: 11642547 [TBL] [Abstract][Full Text] [Related]
4. Aberrant FHIT transcripts in human colorectal cancers. Lee SH; Lee SH Res Commun Mol Pathol Pharmacol; 2005; 117-118():153-65. PubMed ID: 18426086 [TBL] [Abstract][Full Text] [Related]
5. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130 [TBL] [Abstract][Full Text] [Related]
6. Expression of the fragile histidine triad gene in normal rat tissues and human kidney cancer cell lines. Lee SH; Kim TJ; Kim HY; Kim JG; Park MK; Woo KM; Kim SH; Hwang KY; Nam HS; Min YK; Cho MH Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):145-57. PubMed ID: 15080505 [TBL] [Abstract][Full Text] [Related]
7. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas. Lee SH; Kim WH; Kim HK; Woo KM; Nam HS; Kim HS; Kim JG; Cho MH Biochem Biophys Res Commun; 2001 Jun; 284(3):850-5. PubMed ID: 11396980 [TBL] [Abstract][Full Text] [Related]
8. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours. Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528 [TBL] [Abstract][Full Text] [Related]
9. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC). Zou TT; Lei J; Shi YQ; Yin J; Wang S; Souza RF; Kong D; Shimada Y; Smolinski KN; Greenwald BD; Abraham JM; Harpaz N; Meltzer SJ Oncogene; 1997 Jul; 15(1):101-5. PubMed ID: 9233782 [TBL] [Abstract][Full Text] [Related]
10. Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development. Lea JS; Ashfaq R; Muneer S; Burbee DG; Miller DS; Minna JD; Muller CY J Soc Gynecol Investig; 2004 Jul; 11(5):329-37. PubMed ID: 15219888 [TBL] [Abstract][Full Text] [Related]
11. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance. McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880 [TBL] [Abstract][Full Text] [Related]
12. [Abnormal expression of the FHIT gene in human primary gastrointestinal cancers]. Duan XM; Zhang GY; Wu ES Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):331-3. PubMed ID: 12205991 [TBL] [Abstract][Full Text] [Related]
13. 5'CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancer. Tzao C; Tsai HY; Chen JT; Chen CY; Wang YC Eur J Cancer; 2004 Sep; 40(14):2175-83. PubMed ID: 15341994 [TBL] [Abstract][Full Text] [Related]
14. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies. Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866 [TBL] [Abstract][Full Text] [Related]
15. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Mao L; Fan YH; Lotan R; Hong WK Cancer Res; 1996 Nov; 56(22):5128-31. PubMed ID: 8912845 [TBL] [Abstract][Full Text] [Related]
16. FHIT mutations in human primary gastric cancer. Gemma A; Hagiwara K; Ke Y; Burke LM; Khan MA; Nagashima M; Bennett WP; Harris CC Cancer Res; 1997 Apr; 57(8):1435-7. PubMed ID: 9108441 [TBL] [Abstract][Full Text] [Related]
17. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines. Simon B; Bartsch D; Barth P; Prasnikar N; Münch K; Blum A; Arnold R; Göke B Cancer Res; 1998 Apr; 58(8):1583-7. PubMed ID: 9563464 [TBL] [Abstract][Full Text] [Related]
18. Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation. Hussain A; Gutiérrez MI; Timson G; Siraj AK; Deambrogi C; Al-Rasheed M; Gaidano G; Magrath I; Bhatia K Genes Chromosomes Cancer; 2004 Dec; 41(4):321-9. PubMed ID: 15384174 [TBL] [Abstract][Full Text] [Related]
19. Expression of truncated FHIT transcripts in cervical cancers and in normal human cells. Matthews CP; Shera K; Kiviat N; McDougall JK Oncogene; 2001 Aug; 20(34):4665-75. PubMed ID: 11498789 [TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines. Yanagisawa K; Kondo M; Osada H; Uchida K; Takagi K; Masuda A; Takahashi T; Takahashi T Cancer Res; 1996 Dec; 56(24):5579-82. PubMed ID: 8971157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]